A. Chiujdea | AMiner学者主页

1C244: Nephon-sparing Surgery in Our Current Clinical Setting: from Guideline Recommendation to Practice

I.A. Nechifor-Boila,A. Borda,A. Loghin, E. Gliga-Baubec, C. Dorobat,O. Martha,O. Malau,A. Chiujdea,D. Porav-Hodade,C. Catarig,O. Golea,S. Nedelcu,

2014European Urology Supplements（2014）

引用

AI阅读

2C177: is Age a Barrier for Percutaneous Nephrolitotomy?

C. Todea-Moga,R.M. Boja,D. Porav-Hodade,A. Chiujdea,C. Chibelean,A. Maier,O. Vida,V. Moldovan, E. Buszi,O. Martha

2014European Urology Supplements（2014）

引用

AI阅读

3MP-2.23: Side Effects and Complications of Intravesical BCG Instillation in the Treatment of Non-Muscle Invasive Bladder Cancer

Orsolya M.,Osan V.,Boja R.,Schwartz L.,Nedelcu S.,Catarig C.,Golea O.,Chiujdea A.,Malau O.,Porav-Hodade D.,Muntoi D.,Uzun B.,

Intravesical immunotherapy of non-muscle invasive bladder cancer of bladder is performed predominant with BCG, a substance which induces an acute inflammatory response in the bladder wall. The authors present their experience concerning the intravesical instillation of BCG in the treatment of non-muscle invasive bladder cancer, emphasizing the most frequent encountered side effects and complications of this method.

2008Urology（2008）

引用

AI阅读

4425Quantitative and Qualitative Assesment of Flow-Metograms in Patients with Unsatisfactory Results after TURP

Martha O.,Osan V.,Schwanz L.,Catarig C.,Golea O.,Malau O., Butuc O.,Vass L.,Uzun B.,Boja R.,Nicolescu D.,Chiujdea A.,

2005European Urology Supplements（2005）

引用

AI阅读

研究兴趣

作者统计

相似学者

研究兴趣

作者统计

相似学者